the role of the multidisciplinary team in providing adequate diagnosis & treatment for bpdcn
Published 1 year ago • 45 plays • Length 2:29Download video MP4
Download video MP3
Similar videos
-
1:18
the importance of lymphodepletion, an undervalued component of the car-t therapy cycle
-
1:09
optimizing car-t outcomes in dlbcl: possible combination strategies & sequencing of agents
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:06
importance of collaboration in car-t
-
1:41
car t-cells: an advancement in treating mm?
-
1:15
allosct outcomes in patients who achieve cr with car-t versus chemotherapy in t-all/lbl
-
1:06
insights into toll-like receptor signaling and implications for car-t therapy
-
1:13
challenges in risk stratifying lr-mds: insights into genetic upstaging and early transplant
-
1:01:36
deciphering car-t cells: exploring functional mechanisms to drive next generation immunotherapy
-
58:17
the quest for provably efficient ml algorithms
-
4:26
ama: wildcard edition - content and collection management systems
-
2:08
car t-cell therapy: co-operation could lead to unprecedented levels of efficacy
-
3:18
evaluating dual-targeting cd19/22 car-t cells in patients with r/r all
-
1:59
efficacy and safety of cd19-targeted car t-cells for relapsed/refractory all
-
3:18
out of specification car t-cells
-
1:06
novel third-generation tlr2 co-stimulatory car-t cells for b-cell malignancies
-
4:34
development and evaluation of a novel car-t cell therapy against calr mutant neoplasms
-
1:50
"off-the-shelf" car-t: future prospects
-
0:42
the importance of genomic characterization in t-all
-
2:55
car-t expectations
-
2:31
relevance trial analysis: investigating the impact of lymphocyte/monocyte ratio on patient outcomes
-
3:47
allo-715 and allo-647: novel car-t products in r/r myeloma